Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.
NCT ID: NCT04946877
Last Updated: 2022-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2022-03-01
2022-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Activity Associated With Inhibition of Action in Attention-deficit
NCT04768556
Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children
NCT03436017
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
NCT03806946
Study on the Quality of Life Among Adolescents With Attention Deficit/Hyperactivity Disorder
NCT03719950
Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
NCT01130467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case group
100 ADHD patients; will be taken from outpatient clinic of child and adolescence psychiatry of Assiut university hospitals.
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .
control group
100 normal children; they will be selected from neurology clinic complaining from minor neurological complaint e.g : headache, will match with the case group for age, sex and educational level.
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)
IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sex: both sexes will be included in the study.
* IQ≥70.
Exclusion Criteria
* IQ\<70.
* Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy.
* Patients with major psychiatric disorders e.g schizophrenia spectrum disorder.
* Patient who refusing to participate in the study or their caregiver refusing to give informed consent.
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salma Mohmed
Doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ahmed Abdelbaky Abd elrahman, MD
Role: CONTACT
References
Explore related publications, articles, or registry entries linked to this study.
Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rastam M, Johnson M, Rothenberger A, Niklasson L. Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I80-92. doi: 10.1007/s00787-004-1008-4.
Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1:15020. doi: 10.1038/nrdp.2015.20.
Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38. doi: 10.1007/s12402-014-0142-1. Epub 2014 Jun 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Comorbidities with ADHD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.